Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Reports Findings in Cell, Nature

Premium

Rosetta Inpharmatics reported findings in Cell and Nature Genetics that highlight how gene expression analysis technologies can be used to decipher the gene function as well as the molecular mechanisms of disease.

The study reported in Nature demonstrated how Rosetta’s FlexJet Arrray technology could be used to understand the basis of molecular events common in cancer.

In the Cell study, Rosetta’s scientists generated a database of gene expression profiles with a variety of phenotypes and employed chemical treatments to systematically analyze the profiles.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.